1 00:00:02,490 --> 00:00:03,310 Sara Dong: Hi everyone. 2 00:00:03,380 --> 00:00:07,469 Welcome to Febrile, a cultured podcast about all things infectious disease. 3 00:00:08,020 --> 00:00:12,020 We use consult questions to dive into ID clinical reasoning, diagnostics, 4 00:00:12,020 --> 00:00:13,549 and antimicrobial management. 5 00:00:14,039 --> 00:00:16,990 I'm Sara Dong, your host and a Med-Peds ID doc. 6 00:00:17,099 --> 00:00:20,819 Before we get started in this episode, I just have a quick announcement. 7 00:00:21,629 --> 00:00:25,739 As Febrile is approaching its fifth anniversary later this year, I've 8 00:00:25,739 --> 00:00:29,863 been reflecting on how much this community has grown, really from 9 00:00:29,863 --> 00:00:33,353 a project that I started in my basement during ID fellowship to 10 00:00:33,353 --> 00:00:36,953 a resource that I'm very proud to continue to work on as junior faculty. 11 00:00:37,743 --> 00:00:42,793 My goal has always been for Febrile to be your go-to for engaging and up-to-date 12 00:00:42,833 --> 00:00:48,893 ID education, as well as a platform that spotlights ID trainees, our community, 13 00:00:49,046 --> 00:00:51,306 the diverse career paths within our field. 14 00:00:51,956 --> 00:00:55,156 But I also wanna make sure that we are adapting along the way, 15 00:00:55,186 --> 00:00:59,886 expanding what we cover, and I have been considering how we can improve. 16 00:01:00,226 --> 00:01:02,666 To do that, I need your help. 17 00:01:03,266 --> 00:01:06,066 I am assembling a Febrile Editorial Board. 18 00:01:06,476 --> 00:01:10,146 I'm looking for enthusiastic, thoughtful, and committed contributors 19 00:01:10,146 --> 00:01:13,446 who want to take a longitudinal role in shaping Febrile's future. 20 00:01:13,533 --> 00:01:17,403 You will truly have a direct and genuine impact on the content 21 00:01:17,466 --> 00:01:20,296 and decisions related to Febrile education moving forward. 22 00:01:20,379 --> 00:01:25,999 I'm looking for Podcast Editors, Visual Editors, so those who may work on 23 00:01:25,999 --> 00:01:30,283 infographics or educational videos, and also Social Media Directors. 24 00:01:31,493 --> 00:01:34,873 Although I have a few projects and positions that I would love to find 25 00:01:34,903 --> 00:01:39,223 individuals for, I'm very much open to suggestions and ideas for roles 26 00:01:39,223 --> 00:01:41,463 that I have not even imagined yet. 27 00:01:41,666 --> 00:01:46,086 This will not replace our model where individuals or teams of episode writers 28 00:01:46,086 --> 00:01:50,306 and guests join for one time or short series of episodes, so I still encourage 29 00:01:50,306 --> 00:01:54,126 you, you know, please reach out to discuss your episode ideas if you have them. 30 00:01:54,236 --> 00:01:56,966 This is really a great way to learn more about the process in 31 00:01:56,966 --> 00:01:58,646 a more time-limited commitment. 32 00:01:59,146 --> 00:02:03,026 But this editorial board will hopefully create a more sustainable model for this 33 00:02:03,026 --> 00:02:07,206 resource and allow it to cover all of the amazing topics and people in ID. 34 00:02:07,493 --> 00:02:09,283 I have posted more details. 35 00:02:09,673 --> 00:02:13,363 You can find them at febrilepodcast.com/editorialboard. 36 00:02:13,813 --> 00:02:17,253 There's information on roles, responsibilities, expected time 37 00:02:17,253 --> 00:02:20,133 commitment, and suggested skills that would make you a good match. 38 00:02:20,286 --> 00:02:22,946 If you're interested or have additional questions, also 39 00:02:22,946 --> 00:02:24,606 please reach out to me directly. 40 00:02:24,736 --> 00:02:27,396 Thank you so much for being a part of Febrile and listening. 41 00:02:28,706 --> 00:02:29,986 Okay, back to the episode. 42 00:02:32,006 --> 00:02:33,356 Let's meet our guests today. 43 00:02:33,436 --> 00:02:35,746 First up, we have Dr. Alok Nimgaonkar. 44 00:02:35,941 --> 00:02:36,831 Alok Nimgaonkar: My name is Alok. 45 00:02:36,831 --> 00:02:39,511 I'm a third-year Internal Medicine resident at Georgetown. 46 00:02:39,511 --> 00:02:42,320 Really longtime listener of Febrile, and really happy to be here. 47 00:02:42,370 --> 00:02:45,190 Sara Dong: He will be starting his ID fellowship at Columbia this summer. 48 00:02:45,456 --> 00:02:48,716 And next is a return visitor to Febrile, Dr. Rebecca Kumar. 49 00:02:48,940 --> 00:02:49,840 Rebecca Kumar: I'm Rebecca. 50 00:02:49,900 --> 00:02:52,540 I am also a big Febrile fan. 51 00:02:52,600 --> 00:02:55,990 I am an ID attending at Georgetown specializing in transplant. 52 00:02:56,072 --> 00:02:57,392 Excited to get started. 53 00:02:57,507 --> 00:03:01,647 Sara Dong: Well, as everyone's favorite cultured podcast, we always ask if 54 00:03:01,647 --> 00:03:05,297 you would be willing to share a little piece of culture, just something 55 00:03:05,297 --> 00:03:07,437 that you like outside of work. 56 00:03:07,827 --> 00:03:10,557 What have you guys been interested in recently? 57 00:03:11,037 --> 00:03:12,747 Alok Nimgaonkar: So, yeah, I'm a longtime lover of film. 58 00:03:12,762 --> 00:03:15,067 I think one movie I saw recently that was really good was 59 00:03:15,067 --> 00:03:16,467 called, It Was Just An Accident. 60 00:03:16,467 --> 00:03:18,327 It was nominated for Best Foreign Feature. 61 00:03:18,337 --> 00:03:21,927 J ust a very moving portrait of contemporary Iran, and the 62 00:03:21,927 --> 00:03:23,877 past and memory and, and trauma. 63 00:03:24,217 --> 00:03:26,657 So would high-highly recommend for anyone interested. 64 00:03:27,519 --> 00:03:31,959 Rebecca Kumar: For me, I have been listening to a lot of Turnstile recently. 65 00:03:31,989 --> 00:03:36,399 They won a Grammy and they're just like a, I don't even know, I guess 66 00:03:36,399 --> 00:03:40,179 they're post-punk or hardcore, but it's a little bit more pop-y than I 67 00:03:40,179 --> 00:03:43,479 would say most of the hardcore that I've heard before in the past is so, 68 00:03:43,929 --> 00:03:46,269 um, I've enjoyed their new album. 69 00:03:47,352 --> 00:03:47,832 Sara Dong: Nice. 70 00:03:48,072 --> 00:03:50,202 I can't remember what you recommended last night. 71 00:03:50,202 --> 00:03:52,242 I think it was an album of some kind. 72 00:03:52,422 --> 00:03:53,082 It's been a while. 73 00:03:54,072 --> 00:03:55,032 We'll have to go back. 74 00:03:55,632 --> 00:04:00,252 Um, all right, well I heard we have a consult question about a 75 00:04:00,252 --> 00:04:02,292 potential drive line infection. 76 00:04:02,292 --> 00:04:03,822 So Alok, I'll hand it off to you. 77 00:04:04,100 --> 00:04:06,745 Alok Nimgaonkar: Yeah so this is a, uh, sixty-three-year-old man with 78 00:04:06,745 --> 00:04:10,462 history of HFrEF from non-ischemic cardiomyopathy of unknown origin. 79 00:04:10,792 --> 00:04:13,465 He had a HeartMate 3 LVAD placed two years ago. 80 00:04:13,465 --> 00:04:17,145 He's presenting with redness, pain, and drainage surrounding his driveline site. 81 00:04:17,555 --> 00:04:19,965 ID is consulted for evaluation and management. 82 00:04:20,159 --> 00:04:22,649 So I think before diving into this case, I think it would be helpful to 83 00:04:22,649 --> 00:04:25,619 review, definitions of MCS and LVADs. 84 00:04:25,726 --> 00:04:28,556 Rebecca Kumar: So, when we talk about MCS, what that stands for is 85 00:04:28,556 --> 00:04:33,640 mechanical circulatory support, and that really describes a range of 86 00:04:33,670 --> 00:04:38,450 devices but essentially all of these devices enhance systemic perfusions 87 00:04:38,690 --> 00:04:42,020 in patients who have cardiogenic shock or advanced heart failure 88 00:04:42,020 --> 00:04:44,240 that's refractory to interventions. 89 00:04:44,600 --> 00:04:48,410 And then when we think about it even further, these MCS systems 90 00:04:48,410 --> 00:04:52,160 can be classified into short term and long term support devices. 91 00:04:52,216 --> 00:04:56,733 So for short term devices, these are ones that support patients through 92 00:04:56,733 --> 00:05:01,383 these high risk, procedures or periods, like cardiogenic shock, for example. 93 00:05:01,383 --> 00:05:04,503 To allo w us to have time to understand their prognosis, to 94 00:05:04,503 --> 00:05:07,969 guide definitive treatment or serve as a bridge to transplant. 95 00:05:07,969 --> 00:05:12,123 And these devices include, the Impella, which is essentially a short term 96 00:05:12,303 --> 00:05:17,986 VAD, um, ventricular assist device, the intraaortic balloon pump or ECMO. 97 00:05:18,876 --> 00:05:22,566 And then long-term support devices are typically used for patients 98 00:05:22,566 --> 00:05:24,126 who have end stage heart failure. 99 00:05:24,156 --> 00:05:29,166 And they can be used as a bridge to transplant, a bridge to decision 100 00:05:29,166 --> 00:05:32,503 on whether or not somebody will qualify for a transplant, or it could 101 00:05:32,503 --> 00:05:34,213 be used as a bridge to recovery. 102 00:05:34,393 --> 00:05:36,523 And really bridge to recovery is pretty rare. 103 00:05:36,523 --> 00:05:39,433 It only occurs in about one to 3% of patients. 104 00:05:39,553 --> 00:05:42,913 And then finally what we're seeing more commonly is that it's being used 105 00:05:42,913 --> 00:05:46,723 as destination therapy, meaning that this is just a device that they will 106 00:05:46,723 --> 00:05:50,713 live with for the rest of their lives to help support their cardiac function. 107 00:05:50,800 --> 00:05:55,720 Long-term support devices are also known as durable mechanical circulatory 108 00:05:55,720 --> 00:05:59,150 support, and the most common one, and the one that we're gonna be talking 109 00:05:59,150 --> 00:06:02,730 about today is the left ventricular assist device . But you can also 110 00:06:02,730 --> 00:06:07,176 get biventricular assist devices or total artificial heart implantation`. 111 00:06:08,584 --> 00:06:10,884 Alok Nimgaonkar: So how do LVADs work, what are their different components? 112 00:06:11,323 --> 00:06:14,293 Rebecca Kumar: So, you know, we talked about this back in 2022 in 113 00:06:14,293 --> 00:06:18,573 the episode Shape of My VAD, so if you wanna go into more detail, please 114 00:06:18,573 --> 00:06:20,283 listen to that podcast episode. 115 00:06:20,583 --> 00:06:24,733 But just very briefly, from the inside out, we have the pump, which if you think 116 00:06:24,733 --> 00:06:29,093 about it, has a component that's in contact with the blood, where the actual 117 00:06:29,093 --> 00:06:32,573 blood goes into the device, and then there's an external surface which doesn't 118 00:06:32,573 --> 00:06:35,063 have any direct contact with the blood. 119 00:06:35,096 --> 00:06:41,266 So the blood goes from the pump into this outflow cannula, which again also has 120 00:06:41,306 --> 00:06:43,016 an area in which blood travels through. 121 00:06:43,016 --> 00:06:44,975 And then there's the outside of the device. 122 00:06:45,016 --> 00:06:48,881 And from there, it goes into the aorta and to the rest of the body. 123 00:06:49,191 --> 00:06:54,008 And the pump itself is powered by an external battery that is connected 124 00:06:54,068 --> 00:06:59,168 to the device via a driveline and the driveline tunnels from outside in 125 00:06:59,168 --> 00:07:03,381 the abdomen through the, through the abdominal cavity into the thoracic 126 00:07:03,411 --> 00:07:05,061 cavity where it connects to the pump. 127 00:07:05,251 --> 00:07:07,311 Alok Nimgaonkar: So, how have trends in utilization of LVADs 128 00:07:07,431 --> 00:07:10,701 as bridge to transplant versus destination therapy changed over time? 129 00:07:10,721 --> 00:07:11,991 And what are the implications? 130 00:07:12,176 --> 00:07:16,136 Rebecca Kumar: There's the INTERMACS study which stands for the Interagency 131 00:07:16,136 --> 00:07:20,173 Registry for Mechanical Assisted Circulatory Support, which noted that 132 00:07:20,173 --> 00:07:26,416 since 2022, that these newer devices like the HeartMate 3 are are exclusively 133 00:07:26,416 --> 00:07:29,956 used compared to older devices, like the HeartMate, like two, et cetera. 134 00:07:30,196 --> 00:07:36,496 Um, and, roughly 80% that were being put in from the years 2021 to 2023 135 00:07:36,496 --> 00:07:38,626 were actually destination therapies. 136 00:07:39,026 --> 00:07:43,586 And again, an LVAD is helpful because essentially there is a shortage 137 00:07:43,586 --> 00:07:45,506 of donors throughout the country. 138 00:07:45,506 --> 00:07:46,406 We know this. 139 00:07:46,656 --> 00:07:50,216 And for patients who don't qualify for a transplant, this is an option 140 00:07:50,216 --> 00:07:52,046 for them in order to live longer. 141 00:07:52,046 --> 00:07:54,836 But LVADS do come with their own risks. 142 00:07:55,116 --> 00:07:59,836 Stroke, thrombosis, infections, these are all complications that can happen 143 00:07:59,836 --> 00:08:06,930 in patients who are living with LVADs, but since the adoption of the HeartMate 144 00:08:06,990 --> 00:08:11,800 three, the risk of stroke, the risk of thrombosis have all decreased. 145 00:08:12,220 --> 00:08:14,160 But, with regards to infection. 146 00:08:15,315 --> 00:08:17,385 The risk is still about the same. 147 00:08:17,775 --> 00:08:21,045 And the longer that you have the LVAD in, the more likely 148 00:08:21,045 --> 00:08:23,025 you are to develop an infection. 149 00:08:23,025 --> 00:08:26,415 So this really means that with the utilization of LVA DS for 150 00:08:26,415 --> 00:08:30,495 destination therapy, that we're having patients who are living longer 151 00:08:30,495 --> 00:08:34,065 with an LVAD in place and are thus more likely to develop infections. 152 00:08:34,065 --> 00:08:37,815 And so I think as ID physicians, we need to have a good understanding 153 00:08:37,845 --> 00:08:42,325 of these durable mechanical circulatory support devices and an 154 00:08:42,325 --> 00:08:46,195 understanding of the infections that are associated with these devices. 155 00:08:46,354 --> 00:08:49,877 Alok Nimgaonkar: So how has the long-term durability of LVADs impacted patient's 156 00:08:49,877 --> 00:08:51,527 ability to move up on the wait list? 157 00:08:51,527 --> 00:08:54,827 And why is this an issue if LVAD outcomes have improved at a comparable level 158 00:08:54,997 --> 00:08:56,077 that of transplants? 159 00:08:57,020 --> 00:09:01,350 Rebecca Kumar: Yeah, so prior to 2018, UNOS listed patients with LVA DS as 160 00:09:01,350 --> 00:09:06,450 either status 1A, if they had any sort of complication or 1B if they did not. 161 00:09:06,820 --> 00:09:12,880 In 2018, essentially UNOS deprioritized patients with long-term LVADs such 162 00:09:12,880 --> 00:09:16,570 that only patients with essentially like a life-threatening ventricular 163 00:09:16,570 --> 00:09:22,330 arrhythmia got moved to status 1 or a device malfunction or mechanical failure. 164 00:09:22,570 --> 00:09:25,900 Those patients ended up as status two, but for everybody else, no 165 00:09:25,900 --> 00:09:29,940 matter how long you had the LVAD in for you were considered status 3. 166 00:09:29,980 --> 00:09:34,990 So even if you have an infection associated with your LVAD, the highest 167 00:09:34,990 --> 00:09:37,090 you can go is only a status three. 168 00:09:37,140 --> 00:09:40,710 So now what we're seeing is that these LVAD patients, even though 169 00:09:40,710 --> 00:09:43,440 they were initially implanted with the thought that it was gonna be a 170 00:09:43,440 --> 00:09:47,820 bridge to transplant, now it's more like a bridge to a complication. 171 00:09:47,820 --> 00:09:50,940 but I do believe that there's been an update in the policy. 172 00:09:50,940 --> 00:09:53,850 And Alok, I know that you have a passion for policy. 173 00:09:53,916 --> 00:09:55,176 Do you wanna update us on it? 174 00:09:55,994 --> 00:09:58,064 Alok Nimgaonkar: Yeah, there's actually a recent proposal that's 175 00:09:58,064 --> 00:10:02,229 been accepted in June that that will allow patients with LVADs to go up 176 00:10:02,229 --> 00:10:05,849 on the listing, um, based on the time that they've had their LVAD in place. 177 00:10:06,249 --> 00:10:09,099 So they, if they've had their LVAD in place for six years, they'd go up to 178 00:10:09,099 --> 00:10:11,859 status three, and then if they've had it for eight years, they would go up 179 00:10:11,859 --> 00:10:15,339 to status two, regardless of whether they've had complications or not. 180 00:10:15,739 --> 00:10:19,826 This should go into effect in September of 2026, with another phase to be 181 00:10:19,826 --> 00:10:21,241 rolled out a year and a half later. 182 00:10:22,253 --> 00:10:25,913 Rebecca Kumar: In that other phase, if I'm not mistaken, shortens 183 00:10:25,913 --> 00:10:29,003 the duration of time the patient needs the LVAD for, correct? 184 00:10:29,003 --> 00:10:33,023 It goes to five years, then they'll be considered status three 185 00:10:33,023 --> 00:10:36,083 and then seven years, and then they'll be considered status two. 186 00:10:36,274 --> 00:10:37,054 Alok Nimgaonkar: That's exactly right. 187 00:10:37,164 --> 00:10:39,554 Um, now shifting gears a bit to the case. 188 00:10:39,654 --> 00:10:44,254 This patient was recently hospitalized for COPD exacerbation, received a course of 189 00:10:44,254 --> 00:10:46,229 antibiotics and steroids with improvement. 190 00:10:47,019 --> 00:10:49,814 He lives alone and gets dressing changes frequently. 191 00:10:50,504 --> 00:10:54,044 Unfortunately he got his battery caught on a chair when he was walking and 192 00:10:54,044 --> 00:10:57,784 the drive line was tugged and the velour of the drive line was exposed. 193 00:10:58,214 --> 00:11:01,694 He then developed redness, warmth, and pain, increased drainage 194 00:11:01,694 --> 00:11:05,684 from his drive line site Um he hasn't had any fevers or chills. 195 00:11:05,714 --> 00:11:07,724 No alarms have gone off on his drive line. 196 00:11:08,064 --> 00:11:12,174 He denies any chest pain, urinary symptoms, cough or other symptoms. 197 00:11:12,492 --> 00:11:16,202 Quickly going through his medical history, so he had HFrEF from 198 00:11:16,252 --> 00:11:18,312 unknown non ischemic cardiomyopathy. 199 00:11:18,652 --> 00:11:22,122 His EF declined until about 10%, he failed medical management 200 00:11:22,122 --> 00:11:23,742 and required inotropic support. 201 00:11:24,112 --> 00:11:26,722 He then had a HeartMate three device placed about two years 202 00:11:26,722 --> 00:11:30,472 prior and since then has had a relatively uncomplicated course. 203 00:11:30,502 --> 00:11:33,862 He's been on aspirin, warfarin and his INRs has been in therapeutic range. 204 00:11:34,232 --> 00:11:36,392 And his LVAD is listed as destination therapy. 205 00:11:36,897 --> 00:11:41,307 Other medical problems are obesity, his BMI 35 and diabetes with an A1C 206 00:11:41,307 --> 00:11:46,247 of 7.1 In terms of his social history, nothing particularly relevant. 207 00:11:46,287 --> 00:11:50,452 And then on exam, his vitals so he is afebrile temperature of 98.8. 208 00:11:51,062 --> 00:11:53,872 His MAP is 80 and he's satting well in room air. 209 00:11:54,352 --> 00:11:57,712 On exam we noticed that there's a confluent area of redness associated 210 00:11:57,712 --> 00:12:01,592 with warmth, induration surrounding the driveline site with mild white-ish 211 00:12:01,612 --> 00:12:03,382 drainage from the site itself. 212 00:12:03,692 --> 00:12:05,612 The area's tender and without any fluctuance. 213 00:12:05,852 --> 00:12:08,462 So how would you think about the initial approach to a patient with 214 00:12:08,462 --> 00:12:13,542 suspected LVAD infection based on the original 2011 definitions of infections 215 00:12:14,467 --> 00:12:18,637 Rebecca Kumar: So back in 2011, the ISHLT released guidelines on the different 216 00:12:18,637 --> 00:12:22,837 types of infections, really to help guide research, diagnosis and management. 217 00:12:23,112 --> 00:12:27,313 These were further divided into VAD specific infections, which are 218 00:12:27,313 --> 00:12:30,643 essentially infections that are occurring because you have the VAD in place. 219 00:12:30,913 --> 00:12:35,683 So that would be something like a pump infection or a driveline infection. 220 00:12:35,683 --> 00:12:39,073 So it's really things that only a person with a VAD can have. 221 00:12:39,184 --> 00:12:42,694 In addition to those infections, they also had VAD related infections. 222 00:12:42,694 --> 00:12:47,764 So these are infections that are made more complicated by the presence of a VAD. 223 00:12:48,004 --> 00:12:54,274 So bloodstream infections, endocarditis, mediastinitis, all of these things can 224 00:12:54,274 --> 00:12:58,054 happen even if you don't have a VAD, but because there's a VAD in place, 225 00:12:58,144 --> 00:13:00,304 the infection is made more complicated. 226 00:13:00,754 --> 00:13:03,094 And then there are of course non-VAD infections. 227 00:13:03,094 --> 00:13:06,544 So like even if you have a VAD, you, you can still get a UTI. 228 00:13:06,544 --> 00:13:10,924 And then in addition, they basically further subclassified the infections 229 00:13:10,924 --> 00:13:16,024 into definite, probable and possible based on microbiologic, clinical, 230 00:13:16,084 --> 00:13:18,364 radiographic, and pathologic criteria. 231 00:13:20,177 --> 00:13:22,612 Alok Nimgaonkar: So what have have been some problems with these definitions 232 00:13:22,612 --> 00:13:23,897 and what is the rationale for an update? 233 00:13:24,616 --> 00:13:27,772 Rebecca Kumar: So the uptake of these guidelines were not 234 00:13:27,772 --> 00:13:31,072 as strong as had been hoped. 235 00:13:31,072 --> 00:13:36,282 There was a meta-analysis of 132 studies that found only 38% use 236 00:13:36,282 --> 00:13:40,902 the ISHLT guidelines for reporting infections, which makes it hard to 237 00:13:40,902 --> 00:13:45,402 accurately research the epidemiology, the diagnosis, and the management of 238 00:13:45,402 --> 00:13:47,142 these different types of infections. 239 00:13:47,502 --> 00:13:51,822 And additionally advances in technology like such as the HeartMate 3, where 240 00:13:51,822 --> 00:13:56,262 there's no longer a pocket mean that the definitions that were created, 241 00:13:56,262 --> 00:14:01,122 such as a pocket infection are no longer relevant in this day and age. 242 00:14:01,842 --> 00:14:06,612 And then additionally, with things like a driveline infection, the 243 00:14:06,612 --> 00:14:11,787 categorization of deep versus superficial doesn't quite capture the complexity 244 00:14:11,847 --> 00:14:16,797 of treatment associated with driveline infections, just based on the depth. 245 00:14:17,007 --> 00:14:20,987 Um, because you could still have a superficial driveline site that has a 246 00:14:20,987 --> 00:14:26,267 multi-drug resistant organism, or it could have a fungal infection that really makes 247 00:14:26,267 --> 00:14:28,517 the management much more complicated. 248 00:14:28,559 --> 00:14:31,877 And then in addition to this, one of the other rationales for 249 00:14:31,877 --> 00:14:36,917 updating was so that the temporary devices could also be included. 250 00:14:36,917 --> 00:14:40,137 So things like ECMO, the Impella, et cetera. 251 00:14:40,497 --> 00:14:44,547 Um, that these definitions could be standardized across devices. 252 00:14:44,853 --> 00:14:47,363 Alok Nimgaonkar: Makes sense, so what are the 2024 definitions? 253 00:14:47,471 --> 00:14:49,181 Rebecca Kumar: Yeah, so these definitions that have been 254 00:14:49,181 --> 00:14:54,731 published by ISHLT encapsulate both durable and acute MCS devices. 255 00:14:55,011 --> 00:14:58,089 I did mention the acute MCS device infections, but we're 256 00:14:58,089 --> 00:14:59,079 not gonna cover them here. 257 00:14:59,079 --> 00:15:02,016 That's like a whole other episode, but in terms of what's 258 00:15:02,016 --> 00:15:04,896 changed from a LVAD perspective. 259 00:15:04,896 --> 00:15:09,466 So they've changed superficial and deep driveline infections to describe 260 00:15:09,526 --> 00:15:11,956 them as complicated or uncomplicated. 261 00:15:12,256 --> 00:15:16,666 And the idea is that the depth of the infection doesn't capture the complexity 262 00:15:16,666 --> 00:15:20,946 of the condition, it's more like what's the organism associated with it? 263 00:15:21,751 --> 00:15:24,901 There's also been a change to include blood contact surface 264 00:15:24,901 --> 00:15:25,771 infections and endocarditis. 265 00:15:26,577 --> 00:15:32,194 So this is essentially an infection in an area that blood flows through. 266 00:15:32,526 --> 00:15:36,636 And in order to make this diagnosis, you need positive blood cultures. 267 00:15:36,666 --> 00:15:40,096 You'd get radiographic or echocardiographic evidence of a 268 00:15:40,096 --> 00:15:44,756 vegetation or a thrombus in the intravascular aspect of the device. 269 00:15:45,129 --> 00:15:47,479 And then you could also look for septic emboli as well. 270 00:15:48,948 --> 00:15:53,097 And systemic signs are likely to occur and appear, but aren't 271 00:15:53,097 --> 00:15:55,787 always there for the diagnosis. 272 00:15:55,997 --> 00:15:58,517 And then there's device specific bacteremia. 273 00:15:58,517 --> 00:16:01,890 So this is a positive peripheral blood culture in a patient who has a 274 00:16:01,890 --> 00:16:04,240 device and it's related to the device. 275 00:16:04,240 --> 00:16:07,800 So an example for this would be like if somebody developed a bacteremia from a 276 00:16:07,800 --> 00:16:11,620 driveline, or if they have persistently positive blood cultures greater than 277 00:16:11,620 --> 00:16:14,140 72 hours apart with the same organism. 278 00:16:14,226 --> 00:16:17,286 Then you also have infections involving the external surface 279 00:16:17,286 --> 00:16:18,846 of the implanted device. 280 00:16:19,156 --> 00:16:22,576 So this is what we would've considered previously, maybe like a pocket infection. 281 00:16:22,576 --> 00:16:25,826 So the outside of the device itself is infected. 282 00:16:26,676 --> 00:16:29,526 Usually to make this diagnosis you need some sort of positive 283 00:16:29,526 --> 00:16:33,676 culture from the tissue or a fluid collection surrounding it. 284 00:16:34,186 --> 00:16:37,166 And again, there may not be systemic signs present. 285 00:16:37,216 --> 00:16:39,766 Alok Nimgaonkar: So we'll apply and then discuss the implications of management 286 00:16:39,766 --> 00:16:41,506 for these definitions later in the case. 287 00:16:41,846 --> 00:16:45,506 What is what's the typical diagnostic approach for patients with suspected LVAD 288 00:16:45,506 --> 00:16:48,936 infections, and what is your threshold to look for deeper source of infections? 289 00:16:49,558 --> 00:16:52,378 Rebecca Kumar: I have a pretty low threshold to look for deeper sources 290 00:16:52,378 --> 00:16:55,378 of infections, but essentially when this patient comes in, I'd wanna 291 00:16:55,378 --> 00:16:57,948 make sure that there's a CBC, a CMP. 292 00:16:58,288 --> 00:17:01,498 I'd wanna make sure that we get cultures from the driveline exit site, 293 00:17:01,498 --> 00:17:04,528 especially because of the fact that you're telling me that there is drainage. 294 00:17:04,528 --> 00:17:08,828 And then in terms of blood cultures, I'd get three sets of blood cultures. 295 00:17:08,828 --> 00:17:13,968 And I generally, again, would recommend getting CT chest/abdomen/pelvis, you 296 00:17:13,968 --> 00:17:17,768 could potentially get an ultrasound, but I prefer looking at CT, so I'll 297 00:17:17,768 --> 00:17:19,778 usually get a CT chest, abdomen, pelvis. 298 00:17:19,891 --> 00:17:23,191 And then you can also consider getting an echocardiogram. 299 00:17:23,191 --> 00:17:26,521 I think the important thing to keep in mind is that in larger studies of 300 00:17:26,551 --> 00:17:32,971 LVAD infections, SIRS criteria only occurred in about like 39% of patients. 301 00:17:32,971 --> 00:17:37,771 And so just because somebody doesn't look like "SIRS"-y based, based on labs, 302 00:17:37,771 --> 00:17:41,551 like you still need to consider infection when you're evaluating the patient. 303 00:17:41,795 --> 00:17:44,435 So what did the labs end up looking like for him? 304 00:17:45,247 --> 00:17:49,177 Alok Nimgaonkar: So, CBC was a pretty unremarkable white count was 5.4, 305 00:17:49,177 --> 00:17:51,627 hemoglobin was 13, platelets were 118. 306 00:17:52,112 --> 00:17:54,637 CMP was also um unremarkable. 307 00:17:54,637 --> 00:17:57,677 Electrolytes and liver function were at baseline and renal 308 00:17:57,677 --> 00:17:59,147 function was also at baseline. 309 00:17:59,547 --> 00:18:02,667 So the cultures we got actually ended up growing Pseudomonas which is 310 00:18:02,667 --> 00:18:06,987 resistant to cefepime and ciprofloxacin, but was sensitive to meropenem. 311 00:18:07,236 --> 00:18:11,266 The CT chest abdomen pelvis that we got was fortunately unremarkable for fluid 312 00:18:11,266 --> 00:18:15,086 collections around the device, but did show some mild fat stranding at the 313 00:18:15,086 --> 00:18:17,036 area surrounding the driveline insertion. 314 00:18:17,436 --> 00:18:20,406 There wasn't any evidence of deeper infection like an abscess. 315 00:18:21,696 --> 00:18:25,216 So so what are some typical pathogens that can cause infections in LVADs? 316 00:18:25,586 --> 00:18:29,036 Rebecca Kumar: So, usually what, what I think of is gram-positives 317 00:18:29,036 --> 00:18:30,686 like Staph epi and Staph aureus. 318 00:18:30,891 --> 00:18:34,346 And Staph aureus is the most common pathogen overall, but 319 00:18:34,346 --> 00:18:38,336 Pseudomonas is actually the culprit in about 25% of cases. 320 00:18:38,336 --> 00:18:41,406 And, we do know other gram-negative organisms can 321 00:18:41,406 --> 00:18:43,356 also cause infections as well. 322 00:18:43,726 --> 00:18:50,171 Gram-negative rods in general, tend to cause drive line exit site infections. 323 00:18:50,271 --> 00:18:55,591 The longer the patient has had the VAD in place for, and there could 324 00:18:55,591 --> 00:18:59,531 be environmental factors that, that are thought to contribute to this. 325 00:18:59,801 --> 00:19:03,031 Hearing that this is Pseudomonas, I would think maybe some sort of 326 00:19:03,031 --> 00:19:05,221 water exposure likely led to this. 327 00:19:05,571 --> 00:19:08,691 Data regarding the percentage of MDR organisms and LVAD 328 00:19:08,691 --> 00:19:10,344 infections is pretty sparse. 329 00:19:10,344 --> 00:19:15,075 There has been a single center study where it was estimated to occur in about 330 00:19:15,135 --> 00:19:21,258 31% of patients, and I think it's also important to keep in mind that these 331 00:19:21,258 --> 00:19:26,321 organisms can form biofilms and that can lead to high rates of recurrence. 332 00:19:27,021 --> 00:19:29,871 Alok Nimgaonkar: So let's say the patient had systemic signs of infection 333 00:19:29,871 --> 00:19:33,321 and other sources have been ruled out, um, and you're worried that 334 00:19:33,321 --> 00:19:36,051 there's a deeper infection, but a CT is indeterminate or negative. 335 00:19:36,871 --> 00:19:40,601 How useful are other modalities like a PET scan or a white cell tag scan 336 00:19:40,601 --> 00:19:41,231 in these cases? 337 00:19:42,449 --> 00:19:46,139 Rebecca Kumar: I mean, my personal opinion is that white cell scans in general 338 00:19:46,139 --> 00:19:53,242 are trash, but I think, um, you know, CTs can have limited specificity for 339 00:19:53,242 --> 00:19:56,002 ruling out deep drive line infections. 340 00:19:56,342 --> 00:20:00,832 And white cell tag scans have poor sensitivity and positive predictive 341 00:20:00,832 --> 00:20:04,692 values, but a PET scan on the other hand has good sensitivity 342 00:20:04,692 --> 00:20:06,689 and positive predictive value. 343 00:20:06,689 --> 00:20:10,692 The problem is, is that it can be very difficult to get one while a 344 00:20:10,692 --> 00:20:14,432 patient's hospitalized due to the financial hurdles associated with it. 345 00:20:14,822 --> 00:20:18,992 I think it can be very helpful if you're very worried that the pump or the 346 00:20:18,992 --> 00:20:26,612 cannula itself is truly infected, but you have to be prepared to fight for it. 347 00:20:26,926 --> 00:20:28,906 Alok Nimgaonkar: So, so bringing it back to the case, how would you 348 00:20:28,906 --> 00:20:33,136 classify this patient according to the new 2024 definitions, and how would 349 00:20:33,136 --> 00:20:35,741 you go about treating their infection? 350 00:20:35,809 --> 00:20:38,279 Rebecca Kumar: So, even though what this is being described 351 00:20:38,279 --> 00:20:40,229 as it's a superficial infection. 352 00:20:40,229 --> 00:20:43,579 It does have the presence of MDR Pseudomonas, which would 353 00:20:43,579 --> 00:20:46,609 cause this infection to actually be considered complicated. 354 00:20:46,664 --> 00:20:50,894 Most simply, they'd receive two weeks, likely longer of 355 00:20:50,984 --> 00:20:52,874 IV meropenem for treatment. 356 00:20:52,929 --> 00:20:54,309 Alok Nimgaonkar: So, let's say this patient had a deeper 357 00:20:54,309 --> 00:20:55,419 infection of the drive line. 358 00:20:55,419 --> 00:20:56,139 How would you approach 359 00:20:56,174 --> 00:20:57,364 management in that case? 360 00:20:57,607 --> 00:20:59,587 Rebecca Kumar: At that point, management would involve a longer 361 00:20:59,587 --> 00:21:02,538 duration of antibiotics, so like six to eight weeks or longer. 362 00:21:02,554 --> 00:21:05,494 I think the other important thing is talking with your surgical 363 00:21:05,494 --> 00:21:08,434 colleagues about whether or not debridement is possible. 364 00:21:08,434 --> 00:21:12,484 Because he has a HeartMate three, the drive line is a modality that 365 00:21:12,484 --> 00:21:15,464 is replaceable, you don't have to remove the whole device itself. 366 00:21:15,464 --> 00:21:16,904 You can exchange the drive line. 367 00:21:17,264 --> 00:21:21,434 So, talking to them, especially for somebody like this who's an older 368 00:21:21,434 --> 00:21:23,594 gentleman, he's living by himself. 369 00:21:23,914 --> 00:21:27,920 Putting him on long-term meropenem would be difficult for him to 370 00:21:27,920 --> 00:21:31,720 have to administer to himself three times a day for a long time. 371 00:21:32,013 --> 00:21:34,333 Alok Nimgaonkar: Makes sense and, let's say that, it was actually 372 00:21:34,333 --> 00:21:35,608 susceptible to ciprofloxacin. 373 00:21:36,263 --> 00:21:38,643 Would you give him chronic suppression given the high rates 374 00:21:38,643 --> 00:21:39,253 of resistance for Pseudomonas. 375 00:21:39,253 --> 00:21:40,553 resistance for Pseudomonas? 376 00:21:40,594 --> 00:21:42,814 Rebecca Kumar: With Pseudomonas, essentially the fluoroquinolones 377 00:21:42,814 --> 00:21:44,374 are only oral option. 378 00:21:44,444 --> 00:21:50,394 Mutations and resistance are common with Pseudomonas, but I think 379 00:21:50,544 --> 00:21:54,654 taking all of it together, this is somebody who I would consider giving 380 00:21:54,814 --> 00:21:56,644 long-term suppressive therapy to. 381 00:21:56,930 --> 00:21:59,930 Alok Nimgaonkar: How do you think about chronic suppressive antibiotics in general 382 00:21:59,930 --> 00:22:02,160 for patients with these deeper infections? 383 00:22:02,245 --> 00:22:04,325 What are, what are some antibiotics that you might choose? 384 00:22:04,802 --> 00:22:07,712 Rebecca Kumar: so the data's pretty sparse and mixed with regards to 385 00:22:07,712 --> 00:22:12,212 the choice of chronic suppressive antibiotic therapy for LVAD infections. 386 00:22:12,242 --> 00:22:14,972 And the guidelines actually don't specifically make any 387 00:22:14,972 --> 00:22:16,592 specific recommendations. 388 00:22:16,652 --> 00:22:21,309 I think as long as you keep in mind that there's really not much data, and 389 00:22:21,309 --> 00:22:25,749 that the two larger studies looking at LVAD infections have shown that there's 390 00:22:25,749 --> 00:22:29,049 like a roughly 30% rate of relapse. 391 00:22:29,289 --> 00:22:32,409 I think when you keep that in mind, you can counsel your patient and 392 00:22:32,409 --> 00:22:36,319 make sure that they're aware that this is likely to still reoccur. 393 00:22:36,419 --> 00:22:40,859 And then for something like Staph I'd use something like doxy or bactrim. 394 00:22:41,229 --> 00:22:43,249 You could also use Keflex as well. 395 00:22:43,645 --> 00:22:45,745 Alok Nimgaonkar: And then coming back to the definitions, broadly 396 00:22:45,745 --> 00:22:48,955 speaking, what are the implications for management of LVAD infections 397 00:22:49,005 --> 00:22:49,595 with these new definitions coming out? 398 00:22:49,595 --> 00:22:49,635 Rebecca Kumar: In the 399 00:22:51,642 --> 00:22:54,927 short term, it may cause you to think about the duration of antibiotics. 400 00:22:55,027 --> 00:22:59,412 For previously defined superficial driveline infections that are actually 401 00:22:59,412 --> 00:23:01,542 more complicated like the MDROs. 402 00:23:01,942 --> 00:23:05,922 I think that in the long term though, it's gonna help with unified 403 00:23:05,922 --> 00:23:11,252 research of devices, especially across the acute and durable mechanical 404 00:23:11,252 --> 00:23:13,112 circulatory support devices. 405 00:23:13,388 --> 00:23:15,398 Alok Nimgaonkar: Is there anything else coming along the horizon that 406 00:23:15,398 --> 00:23:20,260 might alter the infection risk of M CS and LVAD specifically? 407 00:23:20,344 --> 00:23:23,794 Rebecca Kumar: There's a lot of interest in transcutaneous electronic transfer 408 00:23:23,794 --> 00:23:27,424 systems, which are basically not having a drive line in place, and I think 409 00:23:27,424 --> 00:23:31,844 that because infections predominantly occur because of the drive line, this 410 00:23:31,844 --> 00:23:37,704 would essentially reduce the risk of infections in our LVAD patients. 411 00:23:39,389 --> 00:23:41,759 Sara Dong: Thanks so much for Alok and Rebecca for joining 412 00:23:42,079 --> 00:23:44,179 this update on VAD infections. 413 00:23:44,482 --> 00:23:47,702 Don't forget to check out the website, febrilepodcast.com, where you'll find 414 00:23:47,702 --> 00:23:51,825 the Consult Notes, our library of ID infographics, a link to that info about 415 00:23:51,825 --> 00:23:55,525 the editorial board applications, as well as a link to our merch store. 416 00:23:56,275 --> 00:23:59,855 Febrile is produced with support from the Infectious Diseases Society of America. 417 00:24:00,335 --> 00:24:03,085 Please reach out if you have any suggestions for future shows or want 418 00:24:03,085 --> 00:24:04,345 to be more involved with Febrile. 419 00:24:04,905 --> 00:24:05,645 Thanks for listening. 420 00:24:05,675 --> 00:24:07,175 Stay safe, and I'll see you next time.